Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Consumer Healthcare Market Research Report by Product, by Distribution, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Consumer Healthcare Market size was estimated at USD 318.02 billion in 2020, is expected to reach USD 340.03 billion in 2021, and is projected to grow at a CAGR of 7.28% to reach USD 520.32 billion by 2027.
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Consumer Healthcare to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Dietary Supplements and OTC Pharmaceuticals.
Based on Distribution, the market was studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets.
Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Consumer Healthcare Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Consumer Healthcare Market, including Abbott Laboratories Inc., American Health Corporation, BASF SE, Bayer AG, Bionova Lifesciences, Boehringer Ingelheim GmbH, Eli Lilly and Company, Endo Pharmaceuticals PLC, Gemini Pharmaceuticals, Geneva Biocare, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Ipsen SA, Jasco Group of Companies, Johnson & Johnson Private Ltd, Koninklijke DSM N.V., Lonza Group Ltd., Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., PureTek Corporation, Reckitt Benckiser (RB) Group PLC, Reckitt Benckiser LLC., ROHN HealthCar, Sanofi S.A., Stanex Drugs & Chemicals Pvt. Ltd, Sterling Pharmaceutical Services LLC, Sun Pharmaceutical Industries Limited, Takeda Pharma, and Teva Pharmaceutical Industries Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Consumer Healthcare Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Consumer Healthcare Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Consumer Healthcare Market?
4. What is the competitive strategic window for opportunities in the Global Consumer Healthcare Market?
5. What are the technology trends and regulatory frameworks in the Global Consumer Healthcare Market?
6. What is the market share of the leading vendors in the Global Consumer Healthcare Market?
7. What modes and strategic moves are considered suitable for entering the Global Consumer Healthcare Market?
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
188.8.131.52. High demand for self-medication
184.108.40.206. Analgesics penetration rising with increasing accessibility
220.127.116.11. Government support to offer affordable and easy access to healthcare
18.104.22.168. Rising geriatric population more prone to contracting diseases
22.214.171.124. Inconsistent regulatory framework in different countries
126.96.36.199. Drastic shift from medication prescription to OTC products
188.8.131.52. Accelerated use of online sources
184.108.40.206. Growing demand for branded products and private labels
220.127.116.11. Prevention of overuse by the consumers
18.104.22.168. Drastic shift from medication prescription to OTC products
5.2. Cumulative Impact of COVID-19
6. Consumer Healthcare Market, by Product
6.2. Dietary Supplements
6.3. OTC Pharmaceuticals
7. Consumer Healthcare Market, by Distribution
7.2. Departmental Stores
7.3. Independent Retailers
7.4. Pharmacies or Drugstores
7.5. Specialist Retailers
7.6. Supermarkets or Hypermarkets
8. Americas Consumer Healthcare Market
8.6. United States
9. Asia-Pacific Consumer Healthcare Market
9.10. South Korea
10. Europe, Middle East & Africa Consumer Healthcare Market
10.8. Saudi Arabia
10.9. South Africa
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories Inc.
12.2. American Health Corporation
12.3. BASF SE
12.4. Bayer AG
12.5. Bionova Lifesciences
12.6. Boehringer Ingelheim GmbH
12.7. Eli Lilly and Company
12.8. Endo Pharmaceuticals PLC
12.9. Gemini Pharmaceuticals
12.10. Geneva Biocare
12.11. GlaxoSmithKline plc
12.12. Glenmark Pharmaceuticals Ltd.
12.13. Ipsen SA
12.14. Jasco Group of Companies
12.15. Johnson & Johnson Private Ltd
12.16. Koninklijke DSM N.V.
12.17. Lonza Group Ltd.
12.18. Novartis AG
12.19. Pfizer Inc.
12.20. Piramal Enterprises Ltd.
12.21. PureTek Corporation
12.22. Reckitt Benckiser (RB) Group PLC
12.23. Reckitt Benckiser LLC.
12.24. ROHN HealthCar
12.25. Sanofi S.A.
12.26. Stanex Drugs & Chemicals Pvt. Ltd
12.27. Sterling Pharmaceutical Services LLC
12.28. Sun Pharmaceutical Industries Limited
12.29. Takeda Pharma
12.30. Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/n7nv56
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900